Search

Your search keyword '"Saura, C."' showing total 878 results

Search Constraints

Start Over You searched for: Author "Saura, C." Remove constraint Author: "Saura, C."
878 results on '"Saura, C."'

Search Results

2. Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis

3. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023

4. ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)

5. Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

9. EE528 Analysis of Non-Pharmacological Cost Savings Derived from the Use of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients with HER2-Positive Breast Cancer in Spain

10. Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01)

11. Usefulness of the baseline risk assessment guidelines to predict cancer therapy-related cardiac dysfunction in early-stage HER2 positive breast cancer

16. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

26. Altered global gene expression profiles in human gastrointestinal epithelial Caco2 cells exposed to nanosilver

27. Gene expression profile at week 2 of neoadjuvant therapy course predicts outcome in HER2-positive breast cancer patients: an explorative analysis from NeoALTTO

29. Toxicity, acute

32. Transition to the new EU CTIS Portal for Regulatory Clinical Trial Submissions: VHIO’s Start-Up Unit Analysis

33. Representation of young adult(19–29 y) and elderly(>75 y) patients populations in an early drug development unit

38. 87P EPClin vs OncotypeDx in invasive lobular cancer (ILC)

39. 92MO Neoadjuvant nivolumab (NIVO) + palbociclib (PALBO) + anastrozole (ANA) for estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2−) primary breast cancer (BC): CheckMate 7A8

45. The Human Microbiome: History and Future

46. Genotoxicity of engineered nanomaterials found in the human environment

47. Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer

50. Author Correction: Sex differences in fear memory consolidation via Tac2 signaling in mice.

Catalog

Books, media, physical & digital resources